Kevin Michael Krause

ANTX

Kevin Michael Krause serves as Chief Strategy Officer at AN2 Therapeutics, Inc. (ANTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$201.3K

Net Position

Net Seller

$201.3K

Companies Traded

ANTX

Active Period

Jan 2024

2 total trades

Most Recent

Sell ANTX

Jan 9, 2024 · $149.4K

Kevin Michael Krause's Insider Trading at AN2 Therapeutics, Inc. (ANTX)

Buys

0 · $0.00

Sells

2 · $201.3K

Total Shares Bought

Total Shares Sold

10,000

ANTX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 9, 2024↗	Sell	7,417	$20.14	$149.4K	0
Jan 2, 2024↗	Sell	2,583	$20.12	$52.0K	0

Related Insiders

Sarah Joanne Williams

officer: Principal Accounting Officer

ANTXSell · Mar 3, 2026

Sanjay Chanda

officer: Chief Development Officer

ANTXSell · Jan 6, 2026

Lucy Day

Chief Financial Officer

ANTXSell · Jan 6, 2026

Lucy Day

officer: Chief Financial Officer

ANTXSell · Jan 6, 2026

Joshua M Eizen

officer: See Remarks

ANTXSell · Jan 6, 2026

Sanjay Chanda

Chief Development Officer

ANTXSell · Jan 6, 2026

Joshua M Eizen

See Remarks

ANTXSell · Jan 6, 2026

Stephen David Prior

Chief Strategy Officer

ANTXSell · Jan 6, 2026

Explore More Insider Trading Data

ANTX Insider Trading Activity

View all insider trades at AN2 Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity